too low imho- sp. npv is circa $2bn aud for 45% JV share @ approx 1/2 the current spot prices of spodumene. they used $1250, it will be closer to $2000USD imho.
no risk on the execution- ganfeng is the partner, doesnt get any better than them. we are way better than LKE or CxO which has a massively higher market cap still...
this is just silly selling guys.
look at sigma's up 7% on NYSE. lithium is still in favour.
General Discussion, page-260
-
- There are more pages in this discussion • 10,391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LLL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $605.0M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| LLL (ASX) Chart |
Day chart unavailable